Story perspectives

Breakthrough Antivenom Targets 18 African Snake Venoms

11/5/2025

Summary

Laustsen-Kiel Develops Antivenom

An international team led by Professor Andreas Hougaard Laustsen-Kiel has developed a broad-spectrum antivenom targeting venom from 18 African snake species.
The product combines eight nanobodies and neutralizes venom from 17 species in laboratory tests.
It provides better protection against tissue damage and reduces immune reactions versus traditional antivenoms.
Clinical trials are expected within two years, aiming for a market-ready product in four years.

Summary

Researchers Innovate Antivenom

Researchers have developed a new antivenom using phage display technology, eliminating the need for animal-derived antibodies.
The antivenom uses nanobodies that penetrate faster and deeper than traditional antibodies, which could reduce local tissue damage.
Nanobodies pose a lower risk of immune reactions.
Production costs could be less than half of current antivenoms because less active substance is required and nanobodies are stable during storage.

1 of 2

Laustsen-Kiel Develops Antivenom

An international team led by Professor Andreas Hougaard Laustsen-Kiel has developed a broad-spectrum antivenom targeting venom from 18 African snake species.
The product combines eight nanobodies and neutralizes venom from 17 species in laboratory tests.
It provides better protection against tissue damage and reduces immune reactions versus traditional antivenoms.
Clinical trials are expected within two years, aiming for a market-ready product in four years.

1 / 2